AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 133 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $229,000 | +10.1% | 11,556 | +17.2% | 0.01% | -8.3% |
Q2 2019 | $208,000 | -34.6% | 9,856 | -42.0% | 0.01% | -7.7% |
Q1 2018 | $318,000 | +10.8% | 16,984 | +5.5% | 0.01% | -13.3% |
Q2 2017 | $287,000 | +28.7% | 16,100 | -13.5% | 0.02% | +50.0% |
Q1 2016 | $223,000 | -27.1% | 18,620 | -13.5% | 0.01% | -33.3% |
Q4 2015 | $306,000 | +33.0% | 21,520 | +9.1% | 0.02% | +66.7% |
Q3 2015 | $230,000 | -25.3% | 19,720 | -4.4% | 0.01% | -18.2% |
Q1 2015 | $308,000 | – | 20,621 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alambic Investment Management, L.P. | 29,423 | $583,000 | 0.44% |
Matarin Capital Management, LLC | 223,184 | $4,426,000 | 0.34% |
Summit Global Investments | 42,725 | $847,000 | 0.10% |
FEDERATED HERMES, INC. | 1,747,921 | $34,661,000 | 0.08% |
ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 347,307 | $6,887,000 | 0.08% |
MARSHALL WACE, LLP | 413,293 | $8,196,000 | 0.06% |
BOSTON ADVISORS LLC | 42,365 | $840,000 | 0.04% |
MARTINGALE ASSET MANAGEMENT L P | 214,444 | $4,254,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 177,321 | $3,516,000 | 0.04% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 231,041 | $4,582,000 | 0.04% |